TIPE2 and central nervous system cancer: Besides, TIPE2 impedes the prostate cancer progression, [19], inhibits hypoxia-induced epithelial mesenchymal transition (EMT) in glioma cells [20], and upregulated in non-hodgkin’s lymphoma [21].